First American Trust, Fsb Bluebird Bio, Inc. Transaction History

First American Trust, Fsb

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$26.16 - $63.5 $331,185 - $803,910	-12,660 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$46.96 - $61.67 $3,709 - $4,871	79 Added 0.63%	12,660 $1.11 Million
Q3 2019 Oct 10, 2019	SELL	$59.47 - $93.1 $5,590 - $8,751	-94 Reduced 0.74%	12,581 $1.16 Million
Q2 2019 Jul 08, 2019	BUY	$75.84 - $105.21 $24,117 - $33,456	318 Added 2.57%	12,675 $1.61 Million
Q1 2019 Apr 09, 2019	BUY	$64.44 - $104.11 $796,285 - $1.29 Million	12,357 New	12,357 $1.95 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of First American Trust, Fsb, based on Form 13F filings with the SEC.

Stay updated on First American Trust, Fsb with notifications on news.